Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies

Status unconfirmed

Conditions studied: Wilms' Tumor, Aniridia

In brief

The goal of this clinical research study is to collect information and blood samples to try to learn why some people develop cancers and tumors, why some families have more cancers than others, and whether certain genes or regions of DNA (the genetic material of cells) affect a person's risk of getting cancer. This is an investigational study. Up to 1500 patients and family members will take part in this study. All will be enrolled at MD Anderson.

Key facts

Study ID

NCT00503893

Run by

M.D. Anderson Cancer Center

People needed

295

Starts

1980-12-01

Expected to finish

2020-12-01

Last updated by the study team

2020-01-27

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients with familial and sporadic Wilm's tumor, genitourinary anomalies, Beckwith-Wiedemann hemihypertrophy and/or aniridia, and family members of patients.

You may not qualify if…

• Patients who do not meet inclusion eligibility criteria are excluded.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.